Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SGOV | ISHARES TR | — | 700,000.0 | $70.5M | 49.86% | — | — | $100.66 | -0.1% |
| 2 | XBI | SPDR SERIES TRUST | — | 284,900.0 | $36.4M | 25.75% | NEW | — | $127.73 | +4.0% |
| 3 | SERA | SERA PROGNOSTICS INC | Healthcare | 2,396,685.0 | $4.9M | 3.44% | NEW | — | $2.03 | -13.3% |
| 4 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 34,800.0 | $658K | 0.47% | NEW | — | $18.90 | +19.8% |
| 5 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 16,000.0 | $613K | 0.43% | -6K | -26.8% | $38.30 | -12.8% |
| 6 | — | ASCENDIS PHARMA A/S | — | 2,500.0 | $572K | 0.41% | -79.0 | -3.1% | $228.73 | — |
| 7 | PHVS | PHARVARIS N V | Healthcare | 20,000.0 | $565K | 0.40% | -511.0 | -2.5% | $28.25 | +4.2% |
| 8 | CYTK | CYTOKINETICS INC | Healthcare | 8,300.0 | $547K | 0.39% | — | — | $65.91 | +18.4% |
| 9 | RPRX | ROYALTY PHARMA PLC | Healthcare | 11,000.0 | $528K | 0.37% | -3K | -20.4% | $47.97 | +10.6% |
| 10 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 6,300.0 | $525K | 0.37% | -48.0 | -0.8% | $83.29 | -3.2% |
| 11 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 8,026.0 | $519K | 0.37% | — | — | $64.63 | +6.0% |
| 12 | EXEL | EXELIXIS INC | Healthcare | 11,948.0 | $512K | 0.36% | — | — | $42.89 | +15.8% |
| 13 | — | DISC MEDICINE INC | — | 8,000.0 | $512K | 0.36% | NEW | — | $63.94 | — |
| 14 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 6,800.0 | $511K | 0.36% | — | — | $75.09 | +0.9% |
| 15 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 15,000.0 | $507K | 0.36% | NEW | — | $33.83 | -14.9% |
| 16 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 3,848.0 | $507K | 0.36% | +114.0 | +3.0% | $131.74 | +18.0% |
| 17 | INCY | INCYTE CORP | Healthcare | 5,300.0 | $499K | 0.35% | -50.0 | -0.9% | $94.12 | +3.5% |
| 18 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 7,000.0 | $491K | 0.35% | +481.0 | +7.4% | $70.15 | -7.6% |
| 19 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 15,000.0 | $488K | 0.34% | +286.0 | +1.9% | $32.54 | -9.5% |
| 20 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 1,465.0 | $485K | 0.34% | +147.0 | +11.2% | $330.87 | -9.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%